NTI endorses the bipartisan Biosecurity Modernization and Innovation Act of 2026, led by Senators Tom Cotton (R-AR) and Amy Klobuchar (D-MN). This bill creates an important opportunity to incentivize a safe and secure U.S. bioeconomy through strengthened biosecurity policy.
“The Biosecurity Modernization and Innovation Act represents a critical opportunity to embed biosecurity into the foundation of America’s strong and growing bioeconomy. By modernizing oversight and fostering collaboration across government, industry, and academia, this legislation helps ensure that scientific and technological progress will strengthen—not jeopardize—national and global security.”
— Hayley Anne Severance, acting vice president, NTI | bio
The legislation advances three core objectives essential to safeguarding innovation:
The bill offers solutions to close gaps in U.S. biotechnology oversight and aligns closely with NTI | bio recommendations for Congressional action. By consolidating and modernizing fragmented approaches to biosecurity and biosafety, the legislation will enable responsible scientific progress, reinforce U.S. biotechnology leadership, and strengthen national and global security.
Sign up for our newsletter to get the latest on nuclear and biological threats.
Policy decisions made today will shape the world's ability to prevent and respond to biological threats for decades to come. Meeting that challenge will require more than expert analysis. It will require collaboration across generations of leaders to engage policymakers and the public.
Ambassadors and officials from African embassies, U.S. government representatives, and health security and philanthropic leaders gathered at NTI on October 7 to discuss how data from the 2026 Africa Health Security Index can guide critical decisions to sustain preparedness across the continent.
New YouGov polling commissioned by NTI and ReThink Media finds that nearly 80 percent of registered voters, across party lines, say it is in the interest of U.S. national security to work with China to mitigate catastrophic threats associated with nuclear risks, AI development, and bioterrorism.
Sign up for regular updates on innovative, real-world solutions to existential threats.
